- Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region.
Isabel Rodriguez-Barraquer1,*, Federico Costa2,3,4,*, Eduardo J. M. Nascimento, Nivison Nery Júnior, Priscila M. S. Castanha, Gielson Almeida Sacramento, Jaqueline Cruz, Mayara Carvalho, Daiana De Olivera, José E. Hagan, Haritha Adhikarla, Elsio A. Wunder Jr., Danilo F. Coêlho, Sasha R. Azar, Shannan L. Rossi, Nikos Vasilakis, Scott C. Weaver, Guilherme S. Ribeiro, Angel Balmaseda, Eva Harris, Maurício L. Nogueira, Mitermayer G. Reis, Ernesto T. A. Marques, Derek A. T. Cummings, Albert I. Ko
Science, 2019; 363: 607-610.
doi: 10.1126/science.aav6618
- Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.
Katzelnick LC, Coello Escoto A, McElvany BD, Chávez C, Salje H, Luo W, Rodriguez-Barraquer I, Jarman R, Durbin AP, Diehl SA, Smith DJ, Whitehead SS, Cummings DAT
PLoS Negl Trop Dis, 2018; 12: 10.
doi: 10.1371/journal.pntd.000686
- Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size.
Salje H, Lessler J, Maljkovic Berry I, Melendrez MC, Endy T, Kalayanarooj S, A-Nuegoonpipat A, Chanama S, Sangkijporn S, Klungthong C, Thaisomboonsuk B, Nisalak A, Gibbons RV, Iamsirithaworn S, Macareo LR, Yoon IK, Sangarsang A, Jarman RG, Cummings DA.
Science, 2017; 355(6331): 1302-1306.
doi: 10.1126/science.aaj9384
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.
Ferguson NM, Rodríguez-Barraquer I, Dorigatti I, Mier-Y-Teran-Romero L, Laydon DJ, Cummings DA.
Science, 2016; 353(6303): 1033-1036.
doi: 10.1126/science.aaf9590
